mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.16 |
0.01 |
mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.01 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.01 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.01 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.01 |